default author photo

Laurence Gladieff

Institut Claudius Regaud

SCHOLARLY PAPERS

2

DOWNLOADS

71

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Parp Inhibitors as Maintenance Therapy in Ovarian Cancer after Platinum-Sensitive Recurrence: Real-World Experience from the Unicancer Network

Number of pages: 25 Posted: 20 Dec 2023 Last Revised: 29 Mar 2024
University Hospital of Limoges, Paoli-Calmettes Institute, University of Paris, University of Claude Bernard Lyon 1 - Medical Oncology Department, Institut Claudius Regaud, Université Paris XI Sud - Gustave Roussy Cancer Campus, Institut de Cancérologie de l’Ouest Pays de Loire, Centre Georges-François Leclerc - Department of Medical Oncology, University of Bordeaux - Department of Medical Oncology, Université de Clermont Auvergne, University of Montpellier - Institute for Cancer Research in Montpellier, University of Lorraine, Centre Henri Becquerel, Institut Curie - Department of Medical Oncology, Institut de Cancérologie de Strasbourg Europe, UNICANCER, Limoges University Hospital and Aix-Marseille-Univ
Downloads 37 (1,236,159)

Abstract:

Loading...

Real word data. PARP inhibitor. Platinum-sensitive. Maintenance therapy. Recurrent ovarian cancer

2.

Association and Performance of Polygenic Risk Scores for Breast Cancer Among French Women Presenting or Not a Familial Predisposition to the Disease

Number of pages: 18 Posted: 08 Sep 2022
INSERM, U900, University of Paris-Saclay, INSERM, U900, INSERM, U900, Paris Dauphine University - PSL Research University, INSERM, U900, University of Paris-Saclay, INSERM, U900, INSERM, U900, University of Paris-Saclay, University of Paris-Saclay, University of Paris-Saclay, University of Paris-Saclay, Centre Georges-François Leclerc, CHU de Brest, Centre François Baclesse, Claude Bernard Lyon 1 University, Paris Dauphine University - PSL Research University, Gustave Roussy, Université Clermont Auvergne, University Hospital Caremeau, Paris Dauphine University - PSL Research University, CHU Hôpital Saint-Jacques, CHU de Montpellier - Arnaud de Villeneuve Hospital, Institut de Cancérologie de l'Ouest, Paris Dauphine University - PSL Research University, Grenoble Alpes University Hospital, Centre Hospitalier de Chambéry, Paris Dauphine University - PSL Research University, CH Georges Renon, Hospices Civils de Lyon, Institut Claudius Regaud, Paris Dauphine University - PSL Research University, Claude Bernard Lyon 1 University, University of Lille - CHU Lille, Hospices Civils de Lyon, Université Cote d'Azur - Hôpital Pasteur, Hôpital Privé du Confluent, Hôpital de Mercy, Centre Antoine Lacassagne, University of Strasbourg - Hôpitaux Universitaires de Strasbourg, François Rabelais University - CHU Bretonneau - CHU Hôpitaux De Tours, Paris Dauphine University - PSL Research University, Centre Georges-François Leclerc, Institut Paoli-Calmettes, Institut Paoli-Calmettes, CHU Saint-Etienne, University of Paris-Saclay, Bergonié Institute, Institut Paoli-Calmettes, Institut Claudius Regaud, CHU Clermont-Ferrand, Centre François Baclesse, Hôpital Universitaire Dupuytren, University of Paris-Saclay, University of Paris-Saclay - INSERM, CESP, Centre National de Recherche en Génomique Humaine, Institut Curie, INSERM, U900 and INSERM, U900
Downloads 34 (1,263,436)

Abstract:

Loading...

breast cancer, genetic susceptibility, BRCA1, BRCA2, SNP, Polygenic risk score, risk prediction